For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...

Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...

Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include ...

January 29, 2025 • Robert F. Kennedy Jr. faced senators today in a contentious confirmation hearing to serve as Health and Human Services Secretary under President Trump. He's a former Democrat ...

By uniting communities and hospitals, patients can be provided with comprehensive continuity of care, which facilitates chronic disease management and follow-up. “…so with the system like this they ...

New data published today shows that 784 patients a day were in hospital with norovirus last week (week ending 19 January 2025), up from 650 the previous week. Levels ...

New guidelines are in place for Alberta doctors who, for safety reasons, decide to reduce the number of patients on their roster. Acknowledging the province's health-care system is under strain ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Use your voice to deepen the dialogue and engage with stories of courage, endurance, community, triumph, and the pursuit of truth in SA.